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缩写 全称（英文） 全称（中文） 
Ag Antigen 抗原 
ADCC Antibody-dependent cell-mediated 
cytotoxicity 
抗体依赖细胞介导的细胞毒作用 
AICD Activation-induced cell death 活化诱导的细胞死亡 
APC Antigen-presenting cell 抗原提呈细胞 
DC Dendrtic cells 树突状细胞 
MST Mean survival time 平均存活时间 
d Day 天 
μl Microliter 微升 
μM Micromolar 微摩尔 
ELISA Enzyme-linked immunosorbent assays 酶联免疫吸附法 
IFN-γ Interferon γ γ 干扰素 
IL-10 Interleukin 10 白介素10 
IL-2 Interleukin 2 白介素 2 
MHC Major histocompatibility complex 主要组织相容物复合体 
min Minute 分钟 
MLR Mixed lymphocyte reactivity  混合淋巴细胞反应 
PCR Polymerase Chain Reaction 聚合酶链式反应 
Tc Cytotoxic T cell 细胞毒性 T 细胞 
TCM Central memory T cells  中枢记忆性 T 细胞 
TCR T cell receptor T 细胞受体 
TEM Effector memory T cells 效应记忆性 T 细胞 
TGF-β Transforming growth factor β  转化生长因子 β 
Th Helper T cell 辅助性 T 细胞 
Tm Memory T cells 记忆性 T 细胞 
Tregs 
VDR 
Regulatory T cells 
Vitamin D receptor 
调节性 T 细胞 





































离得到同种反应性 CD4+Tm，通过体外细胞学实验研究 1,25(OH)2D3 对 CD4
+Tm






制作用只能被外源性 IL-2 部分逆转。在过继转移 CD4+Tm 的裸鼠心脏移植模型
中应用 1,25(OH)2D3 治疗，移植物平均生存时间（mean survival time，MST）从
6.5 天延长到 20.2 天。与对照组相比，1,25(OH)2D3 治疗后受体鼠体重未见明显
下降，但血清总 Ca2+ 水平有一定程度的升高。移植物病理学实验提示移植物中
免疫损伤细胞浸润减少，组织损伤明显减轻。移植物中 IL-2、IFN-γ 和 Foxp3 的
相对基因表达量下降，而 IL-10 的相对基因表达量上升。受体鼠血清中 IFN-γ 和
IL-2含量显著下降，而 IL-10含量呈增加趋势。在受者鼠脾脏和淋巴结中，CD4+Tm




该发现对开发针对 CD4+Tm 的免疫抑制剂提供了一个很好的研究方向。 
 





























Objective: Donor-reactive memory T cells mediated transplant rejection is difficult 
to overcome and known as a major obstacle in the field of organ transplantation. 
CD4+Tm, one key member of the Tm family, plays an irreplaceable role in transplant 
rejection. In this study, by using of 1,25(OH)2D3 to suppress immune activity of 
CD4+Tm in vitro and in vivo, we achieve to inhibit acute allograraft rejection and 
prolong allograft survival time, and to explore mechanism of this action. 
Methods: Skin transplantation was conducted between allogeneic mice. 4-12 
weeks after skin transplantation, pre-sensitized CD4+Tm were isolated from recipient 
spleen and were programmed of immunosuppressive properties on CD4+Tm in vitro. 
Within 7 days, after CD4+Tm were adoptively transferred to nude mice, heterotopic 
vascularized heart transplantation was performed from C57BL/6 to naive nude mice. 
Exploring optimal therapeutic dose, recording recipients body weight and drawing 
survival time curves were developed when 1,25(OH)2D3 was applied to this model 
from day -3 to day 10. 
Results: In vitro, proliferation of CD4+Tm was significantly inhibited by 
1,25(OH)2D3 and was partly restored following exogenous IL-2 addition. Compared 
with the control group, mean survival time of cardiac allografts in the 1,25(OH)2D3 
group was prolonged from 6.5 to 20.2 days. No significant change of recipients body 
weight but higher serum calcium level was observed after 1,25(OH)2D3 treatment. 
Five days after transplantation, although IL-2 and IFN-γ were reduced in recipient 
grafts and sera by 1,25(OH)2D3 treatment, that of IL-10 increased correspondingly. 
Graft pathology suggested that inflammatory infiltration and tissue damage in the 
allograft was significantly reduced. The proportions of CD4+Tm and Tregs, both in 
recipient spleen and lymph nodes, were lowered by 1,25(OH)2D3 when compared with 
the control group. 
Conclusion: 1,25(OH)2D3 can inhibit accelerated rejection mediated by CD4
+Tm 
and prolong allogrfts survival by possible mechanism of inducing clonal deletion or 
clonal anergy. These results may provided a favorable theory for exploiting 
1,25(OH)2D3 as a novel immunosuppressant aimed at alloreactive CD4
+Tm. 
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